EMPAGLIFLOZIN

69480 reported adverse events

Drug classes: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]

These side effects are most commonly reported by patients taking EMPAGLIFLOZIN:

# Side effect Count
0 DIABETIC KETOACIDOSIS 3903
1 NAUSEA 3728
2 DIARRHOEA 3406
3 BLOOD GLUCOSE INCREASED 3255
4 FATIGUE 3031
5 WEIGHT DECREASED 3000
6 OFF LABEL USE 2916
7 VOMITING 2802
8 DIZZINESS 2775
9 DYSPNOEA 2526
See all common reactions for EMPAGLIFLOZIN

EMPAGLIFLOZIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2079 0.5030
1 KETOACIDOSIS 1524 0.2034
2 BLOOD KETONE BODY INCREASED 153 0.1959
3 DIABETIC KETOACIDOSIS 3903 0.1623
4 KETONURIA 121 0.1486
5 STEROID DEPENDENCE 124 0.1412
6 CATARRH 123 0.1361
7 BALANOPOSTHITIS 111 0.1350
8 KETOSIS 146 0.1346
9 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 142 0.1185
See all enriched reactions for EMPAGLIFLOZIN